
Ensysce Biosciences Regains Full Compliance with Nasdaq
Published on December 23, 2024
Ensysce to fund its continued operations, including its planned clinical trials; the dilutive effect of stock issuances from our fundraising
Other news

Ensysce to fund its continued operations, including its planned clinical trials; the dilutive effect of stock issuances from our fundraising